EichorEICHOR
Location: Snellville Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Snellville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · EBGS Clinical Research Center · Eli Lilly and Company · NCT07369011Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07484217Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
NA · Renew Health Clinical Research · Coologics, Inc · NCT06983041A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · EBGS Clinical Research Center, LLC-Site Number 8400037 · Sanofi · NCT07184931Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Phase 3 · Accelerated Clinical Trial · LB Pharmaceuticals Inc. · NCT07363577Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Cornea
Phase 3 · Woolfson Eye Institute · Woolfson Eye Institute · NCT07135167Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · Extraordinary Family Healthcare · Pfizer · NCT05156398A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Phase 3 · Eastside Bariatric and Gen Surg · Novo Nordisk A/S · NCT07253285Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Suburban Hematology Oncology Associates - Snellville · National Cancer Institute (NCI) · NCT04267848Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants
Phase 2 · Accelerated Clinical Trials, LLC · Altesa Biosciences, Inc. · NCT07610395Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Suburban Hematology Oncology Associates - Snellville · SWOG Cancer Research Network · NCT03851445A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Phase 2 · Research Site · Maze Therapeutics · NCT06830629Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years
Phase 3 · Research Site · AstraZeneca · NCT06307665Study of ALTO-300 in MDD
Phase 2 · Site 208 · Alto Neuroscience · NCT05922878NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06963034A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase 2 · Mirador Therapeutics Selected Site · Mirador Therapeutics, Inc. · NCT07113522A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2 · Clinical Site · MapLight Therapeutics · NCT06887192A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Phase 3 · Accelerated Clinical Research Group LLC · Janssen Research & Development, LLC · NCT07573176A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are Hi
Phase 3 · Renew Health Clinical Research ( Site 3760) · Merck Sharp & Dohme LLC · NCT0666770052-week Open Label Safety-Tolerability Study
Phase 3 · Accelerated Clinical Trial · LB Pharmaceuticals Inc. · NCT07369154An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · EBGS Clinical Research Center, LLC - Site Number: 8400037 · Sanofi · NCT07184996Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposur
Phase 3 · Woolfson Eye Institute · Woolfson Eye Institute · NCT07124910Study of ALTO-101 in Patients With Schizophrenia
Phase 2 · Site 5064 · Alto Neuroscience · NCT06502964Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder
Phase 3 · Accelerated Clinical Research Group LLC · Janssen Research & Development, LLC · NCT06559306
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.